Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > SIGA SIGA Technologies > Main Composition
SIGA SIGA Technologies
24.750
-0.040-0.16%
Post Mkt Price
24.650
-0.1-0.40%
All
YOY
Do not show
Business Unit:USD
nameYOYOperating income%
Product sales and supportive services--126.8M94.86%
Research and development--6.87M5.14%
Region Unit:USD
nameYOYOperating income%
United States--133.67M100.00%
Company Overview More
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
CEO: Gomez III, M.D., Ph.D., Phillip Louis
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top